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ABSTRACT Herbal drugs have been used since ancient times to treat a wide range of diseases. Morinda citrifolia Linn
(popularly known as ‘‘Noni’’) has been used in folk medicine by Polynesians for over 2,000 years. It is reported to have a
broad range of therapeutic effects, including effects against headache, fever, arthritis, gingivitis, respiratory disorders, in-
fections, tuberculosis, and diabetes. The aim of this study was to investigate the antioxidant, anti-inflammatory, anti-
nociceptive, and antibacterial properties of the aqueous extract from M. citrifolia leaves (AEMC). Antioxidant activity was
observed against lipid peroxidation, nitric oxide, and hydroxyl radicals. The antinociceptive effect of AEMC was observed in
the acetic acid–induced writhing test at the higher dose. Moreover, AEMC significantly reduced the leukocyte migration in
doses of 200 and 400mg/kg and showed mild antibacterial activity. Together, the results suggest that properties of M.
citrifolia leaf extract should be explored further in order to achieve newer tools for managing painful and inflammation
conditions, including those related to oxidant states.
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INTRODUCTION
Morinda citrifolia Linn, popularly known as‘‘noni,’’ has been used in traditional Polynesian
medicine for over 2,000 years. M. citrifolia (Rubiaceae) is
native from southeast Asia to Australia and is cultivated in
Polynesia, India, the Caribbean region, and central and
northern South America.1,2 Cultures native to these regions
favored using M. citrifolia for treating major diseases and
used it for nourishment in times of famine. Noni fruit has
been recognized by cultures as an excellent source of nu-
trition.3 Noni leaves have been consumed as a vegetable by
many cultural groups. For this reason, it is included in the
World Health Organization’s and Food and Agriculture
Organization’s food composition tables for East Asia and the
Islands of the Pacific.4
About 160 phytochemical compounds in the noni plant
have already been identified, and the major secondary
metabolites are phenolic compounds, organic acids, and
alkaloids.5 Phenolic compounds are examples of herbal
compounds with widely reported antioxidant and anti-
inflammatory properties.
Whereas noni juice and fruit have been well characterized
chemically and pharmacologically,1–3 few data are available
regarding the properties of M. citrifolia leaves. Despite the
lack of experimental data on potential therapeutic proper-
ties, the use of noni for different purposes is still widespread
in many parts of the world. However, infusions prepared
with the aerial parts (stems and leaves) of noni are used in
folk medicine in northeast Brazil to treat painful conditions
and as a sedative. Thus, the aim of the present study was to
evaluate the antioxidant, antibacterial, antinociceptive, and
anti-inflammatory properties of aqueous extracts from M.
citrifolia leaves (AEMC).
MATERIAL AND METHODS
Samples
M. citrifolia leaves were collected in Sa˜o Cristo´va˜o,
Sergipe, Brazil [1018020.7†(S); 36039’7.2†(W)]. Herbarium
voucher specimens (registry number 13503) were prepared
and deposited at the Department of Biology of the Federal
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University of Sergipe. The AEMC was prepared by boiling
in distilled water (7.5%; w/v) for 15 minutes; the solvent
evaporated under reduced pressure and lyophilized.
Phytochemical screening
To detect the presence of various chemical constituents in
AEMC, phytochemical screening was performed according
to the method described by Matos.6 The extract was quali-
tatively analyzed for the presence of phenols, condensed
tannins, alkaloids, volatile coumarins, flavonoids, saponins,
and triterpenes. This analysis was conducted by observing
colorimetric variation after the addition of specific reagents.
Total phenolic content
The total phenolic content was assayed by using the Folin–
Ciocalteu reagent, following a slightly modified version of
Singleton and colleagues’ method.7 The AEMC (100mg)
was diluted to 100mL of water. An aliquot (100lL) of
AEMC was added to 6mL of deionized water and 500lL of
the Folin–Ciocalteu reagent. The mixture was shaken for 1
minute. After addition of 2mL of 15% Na2CO3 solution, the
mixture was shaken for 0.5 minute. The solution was then
diluted with deionized water to a final volume of 10mL.
After incubation for 120 minutes at 23C, the total phenolic
content was determined by using a spectrophotometer at
750 nm. Gallic acid was used as the standard, and total phe-
nolic content was expressed as gallic acid equivalents (g/kg
of AEMC) through the calibration curve with gallic acid. The
calibration curve range was 50–500mg/mL (R2= 0.998).
High-performance liquid chromatography–photodiode-
array detection analysis
The high-performance liquid chromatography (HPLC)
analyses were performed on a liquid chromatograph (Pro-
minence, Shimadzu, Kyoto, Japan) that was equipped with a
vacuum degasser (DGU-20A3), autosampler (SIL-10A), 2
high-pressure pumps (LC-6A), and a photodiode-array de-
tector (DAD) system (SIL-10A) coupled with a CBM 20A
interface. Data were collected by using LC Solution soft-
ware (Shimazdu). Analysis was performed on the analytical
C18 Luna column (250mm · 4.6mm interior diameter; 5-
lm particle diameter; Phenomenex, Torrance, California,
USA) under the following conditions: flow rate 1.0mL/
minute and injection volume of 25lL, with mobile phase
consisting of water and acetonitrile. The gradient elution for
samples was as follows: 5%–50% (acetonitrile) in 30 min-
utes, 50%–100% (acetonitrile) in 5 minutes, 100% (aceto-
nitrile) in 3 minutes. The DAD was set at 254 nm for
acquiring chromatograms, and ultraviolet spectra were re-
corded between 190 and 800 nm. Identification was based on
co-injections of the reference compounds and comparisons
of absorption spectra.
In vitro experiments: antioxidant activity
Thiobarbituric acid test. We used the thiobarbituric
acid reactive species (TBARS) assay to quantify lipid per-
oxidation and an adapted TBARS method to measure the
antioxidant capacity of AEMC, with egg yolk homogenate
used as the lipid-rich substrate.8–10 Briefly, egg yolk was
homogenized (1% w/v) in 20mM phosphate buffer (pH,
7.4), and 1mL of homogenate was sonicated. Lipid pero-
xidation was induced by addition of 0.1mL of 2,20-azobis
(2-amidinopropane) dihydrochloride (AAPH) solution
(0.12M). Reactions were carried out for 30 minutes at 37C.
After cooling, AEMC (0.5mL) was centrifuged with 0.5mL
of trichloroacetic acid (15%) at 1200 g for 10 minutes. An
aliquot of 0.5mL from supernatant was mixed with 0.5mL
thiobarbituric acid (0.67%) and was heated at 95C for 30
minutes. After cooling, the absorbance of the samples was
measured by using a spectrophotometer at 532 nm. The re-
sults are expressed as percentage of TBARS formed by
AAPH alone (induced control).
Nitric oxide–scavenging assay. Nitric oxide was gen-
erated from sodium nitroprusside and measured by using the
Griess reaction. Sodium nitroprusside in aqueous solution at
physiologic pH spontaneously generates nitric oxide, which
interacts with oxygen to produce nitric ions that can be es-
timated by using the Griess reagent. Scavengers of nitric
oxide compete with oxygen, thereby reducing production of
nitric ions. Sodium nitroprusside (5mM) in phosphate-
buffered saline was mixed with 3.0mL of different con-
centrations (1, 10, 100lg/mL and 1mg/mL) of AEMC and
incubated at 25C for 60 minutes. The samples were added
to Griess reagent (1% sulfanilamide, 2% H3PO4, and 0.1%
napthylethylenediamine dihydrochloride). The absorbance
of the chromophore formed during the diazotization of ni-
trite with sulfanilamide and subsequent coupling with nap-
thylethylenediamine was measured at 546 nm.11
Hydroxyl radical–scavenging assay. Hydroxyl radicals
were generated by a Fenton system (FeSO2-H2O2). When
exposed to hydroxyl radicals, the sugar deoxyribose is
degraded to malonaldehyde, which generates a pink chro-
mogen on heating with thiobarbituric acid at low pH. The
method for determining the scavenging on hydroxyl radi-
cals was performed according to a previously described
procedure.12
In vitro experiments: antibacterial activity
Microdilution assays. Microorganisms were obtained
from the American Type Culture Collection and were
available in the Laboratory of Mycological Research at the
Federal University of Santa Maria, Brazil.
The microdilution method was used for antibacterial ac-
tivity tests, as recommended by the National Committee for
Clinical Laboratory Standards.13 Media were placed into
each of 96 wells of the microplates. AEMC solutions at 256
and 512mg/mL were added into the first rows of the mi-
croplates, and 2-fold dilutions of the compounds (256–
0.06mg/mL) were made by dispensing the solutions to the
remaining wells. Ten-microliter culture suspensions were
inoculated into all the wells. The sealed microplates were
incubated at 35C for 24 hours in a humid chamber. The
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lowest concentration of the extracts that completely inhibit
macroscopic growth was determined, and minimum inhib-
itory concentrations (MICs) were reported. Antimicrobial
activity of the AEMC was tested against gram-positive and
gram-negative bacteria.
To classify the activity of the extract, the following criteria
were observed: MIC up to 100lg/mL is considered to indi-
cate good antimicrobial activity; MIC from 100 to 500lg/mL
is considered to represent moderate activity; and MIC greater
than 1,000lg/mL is considered to show inactivity.14–16
In vivo experiments
Animals. Male Swiss mice (25–30 g) were kept in a
controlled-temperature room (mean temperature – standard
deviation, 21C – 2C) with light/dark cycles of 12 hours
each and were allowed free access to food (Purina chow)
and water. Experimental protocols and procedures were
approved by the Federal University of Sergipe Animal Care
and Use Committee (no. 27/09).
Pharmacologic experiments. All nociception and anti-
inflammatory tests were carried out by the same observer,
and experiments were conducted in a quiet room at constant
temperature of 23C. Drugs were administered orally at a
dose/volume of 0.1mL/10 g.
Antinociceptive activity: acetic acid–induced writhing. This
test was performed according to the methods of Koster
et al.17 and Broadbear et al.18 Abdominal contractions were
induced by intraperitoneal injection of a 0.9% solution of
acetic acid (10mL/kg) in mice (n = 6 per group). The ani-
mals in different groups were treated with AEMC (100, 200,
and 400mg/kg orally), the reference drug (morphine, 3mg/
kg, or acetylsalicylic acid, 200mg/kg), and vehicle (saline)
60 minutes before the acetic acid administration. The
number of muscular contractions was counted for 15 minute.
after injection.
Anti-inflammatory activity: leukocyte migration to the
peritoneal cavity. Leukocyte migration was induced by
intraperitoneal injection of carrageenan (1%, 0.25mL) into
the peritoneal cavity of mice 60 minutes after administration
of AEMC (100, 200, and 400mg/kg orally), dexamethasone
(2mg/kg subcutaneously), or vehicle by modification of the
technique previously described by Matos et al.19 The animals
(n= 6 per group) were anesthetized with sodium pentobarbital
(50mg/kg intraperitoneally) and were euthanized by cervical
dislocation 4 hours after carrageenan injection. Shortly after,
saline containing EDTA (1mM, 3mL) was injected intra-
peritoneally. Immediately a brief massage was done for fur-
ther fluid collection; the fluid was centrifuged (1000· g,
5min) at room temperature. The supernatant was disposed
and the precipitate was resuspended in saline. An aliquot of
10lL from this suspension was dissolved in 200lL of Turk
solution, and the total cells were counted in a Neubauer
chamber under optic microscopy. The results were expressed
as the number of neutrophils/mL. The percentage of the
leukocyte inhibition= (1-T/C)· 100, where T represents the
treated groups’ leukocyte counts and C represents the control
group’s leukocyte counts.
Statistical analysis
The data were evaluated by 1-way analysis of vari-
ance followed by the Tukey test. The results are expressed
as the means – standard error to show variation in groups.
Data were analyzed by using Prism software, version
5.0 (GraphPad, La Jolla, CA, USA), and differences were
considered significant when the P value was less than .05.
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FIG. 1. High-performance liquid chromatograms at 254 nm of aqueous extract from Morinda citrifolia leaves and spiked with rutin. Kaempferol
glycosides (peaks 1 and 3) and rutin (peak 2).
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RESULTS AND DISCUSSION
The AEMC was chemically analyzed (qualitative meth-
od). The phytochemical screening of AEMC showed the
presence of alkaloids, coumarins, flavonoids, tannins, sa-
ponins, steroids, and triterpenoids. Total phenolic content of
the extract was 196.8mg of phenolic equivalents (gallic
acid) per gram of extract.
Qualitative analysis of AEMC was also performed by
HPLC. Figure 1 shows the chromatographic profiles of
AEMC and standards; good separation and resolution of
peaks are visible. The phenolic compounds were charac-
terized by retention times relative to external standards,
peak spiking, and comparison of their ultraviolet spectra
with the literature. HPLC-DAD analysis of the aqueous
extract from leaves of noni revealed the presence of 3 major
compounds (peaks 1–3), all showing ultraviolet spectra
typical of flavonols.20 The flavonols identified in noni are
derivatives of quercetin and kaempferol.21,22 According to
the results, flavonoids are present in the AEMC analyzed by
HPLC-DAD, and, on the basis of the use of commercial
standards, peak 2 was identified as quercetin-3-O-rutinoside
(rutin). According to the published data on the ultraviolet
spectra (Fig. 2) and the elution sequence in HPLC-DAD,
peaks 1–3 were suggested as kaempferol glycosides.23 Ac-
cording to Deng et al.,23 flavonol glycosides, mainly rutin,
are the major compounds in noni leaves.
It has been proposed that phenolic compounds are anti-
oxidants and anti-inflammatory agents. Furthermore, much
attention has been given to the relationship between the
antioxidant and anti-inflammatory properties of phenolic
compounds in vitro and in vivo.24 Another anti-inflammatory
property of phenolic compounds (e.g., flavonoids) is their
ability to inhibit neutrophil degranulation.25 Indeed, studies
have shown that certain flavonoids downregulate nitric oxide
production in response to inflammatory stimuli.26
In addition, specific flavonoids are known to chelate
iron, thereby removing a causal factor for the development
of free radicals. Direct inhibition of lipid peroxidation is
another protective measure. Selected flavonoids can re-
duce system complement activation, thereby decreasing
the adhesion of inflammatory cells to the endothelium
and in general resulting in a diminished inflammatory
response.25
Thiobarbituric acid test
Lipid peroxidation has been defined as the biological
damage caused by free radicals that are formed under oxi-
dative stress.27 Several plant extracts have been shown to
inhibit lipid peroxidation, as measured by TBARS results.
The lipids in membrane are continuously subjected to oxi-
dant challenges. Oxidant-induced abstraction of a hydrogen
atom from an unsaturated fatty-acid chain of membrane
lipids initiates the process of lipid peroxidation, which
propagates as a chain reaction. In the process, cyclic per-
oxides, lipid peroxides, and cyclic end peroxides are gen-
erated, which ultimately are fragmented into aldehydes such
as malondialdehyde.28
AEMC (all doses) inhibited the amount of TBARS gen-
erated by AAPH (Fig. 3), indicating a protective effect
against lipid peroxidation. This result suggests that the
AEMC may exert antioxidant protection on biomolecules
such as phospholipids, triacylglycerols, and polyunsaturated
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FIG. 2. Photodiode array ultraviolet spectra of flavonol glycosides
(peaks 1–3) of aqueous extract from Morinda citrifolia leaves. AU,
arbitrary units.
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fatty acids in vivo, which are lipids essential to cellular
membrane function and paracrine signaling.
Hydroxyl radical–scavenging assay
The hydroxyl radical is an extremely reactive species
formed in biological systems and has been implicated as a
highly damaging species in free radical pathology. This
radical has the capacity to join nucleotides in DNA and
cause strand breakage, which contributes to carcinogenesis,
mutagenesis, and cytotoxicity.11,29,30 The hydroxyl radical–
scavenging capacity of an extract is directly related to its
antioxidant activity. The highly reactive hydroxyl radicals
can cause oxidative damage to DNA, lipids, and proteins.11
We observed that the AEMC reduced deoxyribose oxida-
tive damage at all concentrations (Fig. 4). The extract was
highly effective in inhibiting hydroxyl damage. All doses
tested (1, 10, and 100 lg/mL and 1mg/mL) exhibited a
significant (P < .05) antioxidant activity, which was similar
to Trolox (Hoffman-LaRoche, Basel, Switzerland), a
synthetic analogue of a-tocopherol used as an antioxidant
standard.
Nitric oxide–scavenging assay
Nitric oxide plays an important role in various types of
inflammatory processes. It is produced by macrophages in
the course of the inflammatory response. It is mutagenic and
can interfere with DNA repair processes.31 In this study, the
AEMC was checked for its inhibitory effect on nitric oxide
production.
To determine the ability of AEMC as a reactive nitrogen
species scavenger, we evaluated the nitric oxide–scavenging
activity by incubating AEMC with sodium nitroprusside, a
chemical inducer of nitric oxide production. Figure 5 shows
that AEMC at doses of 100lg/mL and 1mg/mL signifi-
cantly decreased nitric oxide production (11% and 19% of
inhibition, respectively).
Microdilution assays
The AEMC showed no activity against the gram-positive
and gram-negative bacteria tested except for Aeromonas
hydrophila (Table 1). This finding could be related to the
absence of anthraquinones in the extract because Chan-
Blanco et al.2 and Wang et al.1 demonstrated the antimi-
crobial activity of this compound.
Acetic acid–induced writhing
Acetic acid–induced writhing is a visceral pain model
widely used to evaluate peripheral antinociceptive activity.
Although this test is a nonspecificmodel (e.g., anticholinergic,
tricyclic antidepressants, and antihistaminic and other agents
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Morinda citrifolia leaves to prevent thiobarbituric acid reactive spe-
cies formation was analyzed. Values represent mean – standard error;
experiments were performed in triplicate. *P < .05, **P < .01,
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FIG. 4. Hydroxyl radical–scavenging activity of aqueous extract
from Morinda citrifolia leaves. Values represent mean – standard
error; experiments were performed in triplicate. ***P < .001 versus
system (analysis of variance followed by Tukey test).
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show activity in this test), it is widely used for analgesic
screening and involves local peritoneal receptors (cholinergic
and histaminic receptors) and the mediators acetylcholine and
histamine.24,32,33 These peripheral nociceptive fibers are
sensitive to both narcotic analgesic (morphine) and nonsteroid
anti-inflammatory drugs, such as aspirin.34
The results depicted in Figure 6 showed that the AEMC
(400mg/kg), given 60 minutes before, produced a signifi-
cant (P < .001) reduction in abdominal constrictions induced
by acetic acid in mice. This result suggests that AEMC may
also help inhibit prostaglandin synthesis because nocicep-
tive mechanisms involve the processing or release of ara-
chidonic acid metabolites via cyclooxygenase and
prostaglandin biosynthesis.35 Because cyclooxygenase may
be activated by nitric oxide,36,37 a possible link between the
antioxidant and antinociceptive activities exerted by AEMC
might be its nitric oxide–scavenging ability.
Leukocyte migration to the peritoneal cavity
To determine the probable anti-inflammatory activity
of AEMC, the peritonitis-induced-by-carrageenan test
was performed in mice. The carrageenan is known to be
an excellent acute inflammatory agent in which fluid
extravasation, leukocyte migration, and biochemical pa-
rameters in the exudate can be easily detected. Injection of
carrageenan on the dorsal surface of mice initiates an in-
flammatory process.38
Because chemotaxis is important in the initiation and
exacerbation of an inflammatory response, our results con-
firm some of the signs of inflammation, such as a decrease in
the leukocyte count, observed in the blood of mice that were
treated by AEMC ingestion.
Figure 7 shows the inhibitory effect of AEMC (200 and
400mg/kg) and dexamethasone (2mg/kg subcutaneously)
on carrageenan-induced responses. There was significantly
(P < .05) decreased leukocyte migration (predominantly
neutrophil migration).
The results of this test showed that the AEMC signifi-
cantly reduced the number of recruited cells. These findings
therefore suggest that AEMC contains active anti-inflam-
matory agents.
The role of nitric oxide in physiologic and pathologic
processes such as inflammation is well-known. It is reported
that nitric oxide itself expresses chemotactic activity.24,39 In
addition, reactive oxygen species and reactive nitrogen
species have also been reported to act as proinflammatory
signals in vivo by stimulating the activation of tumor ne-
crosis factor-a, interleukin-1b, and interleukin-6 genes
through the activation of the redox-sensitive transcription
factor nuclear factor-jB. 40 The antinociception and anti-
inflammatory effects induced by AEMC could thus also be a
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FIG. 6. Effects of aqueous extract from Morinda citrifolia leaves on
the acetic acid–induced writhing test. Vehicle (control), aqueous extract
(100, 200, and 400mg/kg), morphine, or acetylsalicylic acid were ad-
ministered orally 0.5 hour before acetic acid injection. Each column
represents mean– standard error (n= 6). ***P< .001 versus control
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Table 1. Inhibitory Concentration of Aqueous Extract
from Morinda citrifolia Leaves Against Bacteria
Microorganisms
ATTC
No.
Gram stain
result
MIC
(mg/mL)
Salmonella typhi 8739 Gram-negative >10
Escherichia coli 9120 Gram-negative 10
Klebsiella pneumoniae 9341 Gram-negative 5
Proteus mirabilis 10031 Gram-negative 5
Pseudomonas aeruginosa 25923 Gram-negative 1.25
Aeromonas hydrophila 29212 Gram-negative 0.625
Micrococcus species 14153 Gram-positive 2.5
Staphylococcus aureus 27853 Gram-positive 2.5
Enterococcus faecalis 7966 Gram-positive 5
ATCC, American Type Culture Collection.
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consequence of its antioxidant ability, which may prevent
the free radical–induced nuclear factor-jB activation and
consequent proinflammatory cytokine production, a cycle
that perpetuates inflammatory processes. 41
CONCLUSION
Our results indicate that AEMC has mild antibacterial
activity and significant antioxidant, antinociceptive, and
anti-inflammatory effects, which provide pharmacologic
evidence for folk uses of M. citrifolia Linn. Other studies
have reported that the M. citrifolia leaf extract contains
polyphenols. Therefore, the biological effects of the leaf
extract may depend on its phenolic components. However,
the dosage used appears to be high, and additional studies
are necessary to evaluate the potential toxicity of the extract
and its possible safe and therapeutically efficient dosage in
humans. In addition, further studies, isolation, and charac-
terization will be undertaken to correlate the pharmacologic
activities with the chemical constituents.
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